Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-related Macular Degeneration Patients: 3-Year Outcomes

被引：0
|
作者：
Wijeyakumar, Wijeyanthy [1 ,2 ]
Zhu, Meidong [1 ,2 ]
Chang, Andrew Alexander [1 ,2 ]
机构：
[1] Sydney Inst Vis Sci, Sydney, NSW, Australia
[2] Univ Sydney, Save Sight Inst, Sydney, NSW, Australia
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2016年 / 57卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
4965
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Three-year Outcomes of Treat and Extend Aflibercept Treatment for Neovascular Age-related Macular Degeneration
    Kataoka, Keiko
    Asai, Keiko
    Tsunekawa, Yuma
    Ito, Yasuki
    Terasaki, Hiroko
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [42] Intravitreal aflibercept outcomes in patients with persistent retinal fluid with prior bevacizumab or ranibizumab treatment for neovascular age-related macular degeneration
    Griffin, David
    Richmond, Preston
    Olson, John
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [43] TWO YEAR OUTCOMES OF "TREAT AND EXTEND" INTRAVITREAL THERAPY USING AFLIBERCEPT PREFERENTIALLY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Barthelmes, Daniel
    Vuong Nguyen
    Daien, Vincent
    Campain, Anna
    Walton, Richard
    Guymer, Robyn
    Morlet, Nigel
    Hunyor, Alex P.
    Essex, Rohan W.
    Arnold, Jennifer J.
    Gillies, Mark C.
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2018, 38 (01): : 20 - 28
  • [44] Aflibercept in the Treatment of Neovascular Age-Related Macular Degeneration in Previously Treated Patients
    Hall, Laura B.
    Zebardast, Nazlee
    Huang, John J.
    Adelman, Ron A.
    [J]. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2014, 30 (04) : 346 - 352
  • [45] Effect of intravitreal aflibercept (Eylea®) on retrobulbar hemodynamics in patients with neovascular age-related macular degeneration
    Gok, Mustafa
    Kapti, Hasan Burhanettin
    [J]. INTERNATIONAL OPHTHALMOLOGY, 2018, 38 (02) : 713 - 719
  • [46] Efficacy of intravitreal aflibercept treatment of pigment epithelial detachment in neovascular age-related macular degeneration refractory to intravitreal ranibizumab: 2-year outcomes
    Ramskold, Louise
    Lee, Han Bin
    Chandran, Manju N.
    Gencheva, Petya
    Menon, Geeta
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [47] Comparison between Aflibercept, Ranibizumab intravitreal injection on Neovascular Age-related macular degeneration patients
    Kwon, Y. H.
    Min, J. S.
    Ahn, H.
    [J]. ACTA OPHTHALMOLOGICA, 2016, 94
  • [48] Intraocular Pressure in Patients with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Aflibercept or Ranibizumab
    Freund, K. Bailey
    Hoang, Quan V.
    Saroj, Namrata
    Thompson, Desmond
    [J]. OPHTHALMOLOGY, 2015, 122 (09) : 1802 - 1810
  • [49] Comparative effectiveness of aflibercept for the treatment of patients with neovascular age-related macular degeneration
    Thomas, Michael
    Mousa, Shaymaa S.
    Mousa, Shaker A.
    [J]. CLINICAL OPHTHALMOLOGY, 2013, 7 : 495 - 500
  • [50] Comparison between Aflibercept, Ranibizumab Intravitreal Injection on Neovascular Age-related Macular Degeneration Patients
    Min, Ji Sang
    Jung, Hyun Chul
    Suh, Ji Young
    Kwon, Yoon Hyung
    [J]. JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2016, 57 (11): : 1738 - 1744
12345